Patent: 9,066,866
✉ Email this page to a colleague
Summary for Patent: 9,066,866
Title: | Direct cellular energy delivery system |
Abstract: | A lipid vesicle comprising a phospholipid which is a stable vesicle former and at least one unstable vesicle forming member, wherein the unstable vesicle forming member is selected from the group consisting of a polar lipid which is not a stable vesicle former, a PEG, a raft former and a fusion protein is provided. The vesicle can further comprise a biomolecule, such as for example ATP. Methods of using the vesicle for delivery of biomolecules are also provided. |
Inventor(s): | Ehringer; William D. (Charleston, IN), Chien; Sufan (Floyd Knobbs, IN) |
Assignee: | University of Louisville Research Foundation, Inc. (Louisville, KY) |
Application Number: | 13/163,546 |
Patent Claims: | see list of patent claims |
Details for Patent 9,066,866
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Smith & Nephew, Inc. | REGRANEX | becaplermin | Gel | 103691 | 12/16/1997 | ⤷ Try a Trial | 2022-05-14 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |